Hai cercato la traduzione di augmentation da Inglese a Maltese

augmentation
Żieda

augmentation may occur.
jista’ jseħħ l-awmentazzjoni.

reduced capacity limited to augmentation
kapaċità ridotta limitata għall-awmentazzjoni

augmentation may occur in restless legs syndrome patients.
jista’ jseħħ l-awmentazzjoni.

augmentation was specifically investigated in a controlled clinical trial over 26 weeks.
l-awmentazzjoni kienet investigata speċifikament fi prova klinika kkontrollata fuq perijodu ta’ 26 ġimgħa.

by extension, it also includes regional augmentation systems such as egnos or its us equivalent, waas.
b'estensjoni, dan jinkludi wkoll is-sistemi reġjonali ta' żieda bħall-egnos jew l-ekwivalenti amerikan tiegħu, id-waas.

reports in the literature indicate that treatment of another indication with dopaminergic medicinal products can result in augmentation.
rapporti fil-letteratura medika jindikaw li l-kura ta’ indikazzjonijiet oħra ma’ prodotti mediċinali dopominerġiċi jista’ jirriżulta fi tħarriex.

augmentation reports in the literature indicate that treatment of restless legs syndrome with dopaminergic medicinal products can result in augmentation.
Żieda rapporti fil- letteratura jindikaw li l- kura tas- sindrome tas- saqajn bla kwiet bi prodotti mediċinali dopaminerġiċi tista ’ tirriżulta f’ żieda.

4.6 the augmentation systems which make it possible to enhance the definition of gps are regionally-based.
4.6 is-sistemi ta’ tiżjid li jippermettu t-titjib tad-definizzjoni tal-gps huma reġjonali.

the frequency of augmentation after longer use of pramipexole and the appropriate management of these events have not been evaluated in controlled clinical trials.
il- frekwenza tat- tħarriex wara użu aktar fit- tul ta ’ pramipexole u l- immaniġġjar xieraq ta ’ dawn l - avvenimenti ma kienux evalwati fil- provi kliniċi b’ kontrolli

in long-term clinical studies with rotigotine, the majority of augmentation episodes were seen in the first and second years of treatment.
f’studji kliniċi fit-tul b’rotigoline, il-maġġoranza ta’ episodji ta’ awmentazzjoni dehru fl- ewwel jew it-tieni sena ta’ trattament.

egnos (european geostationary navigation overlay service) is europe’s regional augmentation system for gps signals.
egnos (european geostationary navigation overlay service) huwa s-sistema ta' awmentazzjoni reġjonali għas-sinjali tal-gps tal-ewropa.

2.5 egnos is a regional satellite-based augmentation system for europe that improves the signals coming from existing satellite navigation systems such as gps.
2.5 egnos hija sistema reġjonali ta’ tisħiħ ibbażata fuq is-satelliti għall-ewropa li ttejjeb is-sinjali li ġejjin minn sistemi ta’ navigazzjoni bis-satellita li jeżistu diġà, bħall-gps.

doses higher than the approved dose range for rls should be avoided as this may lead to higher rates of augmentation (see section 5.1).
dożi ogħla mill-medda ta’ dożi approvati għal rls għandhom jiġu evitati għaliex din tista` twassal għal rati ogħla ta’ awmentazzjoni (ara sezzjoni 5.1).

augmentation refers to the earlier onset of symptoms in the evening (or even the afternoon), increase in symptoms, and spread of symptoms to involve other extremities.
iż- żieda tirreferi għall- bidu iktar bikri tas- sintomi filgħaxija (jew anki wara nofsinhar), żieda fis - sintomi, u li s- sintomi jinfirxu u jinvolvu estremitajiet oħrajn.

augmentation was observed in 11.8% of patients in the pramipexole group (n = 152) and 9.4% of patients in the placebo group (n = 149).
l-awmentazzjoni kienet osservata fi 11.8% tal-pazjenti fil-grupp ta’ pramipexole (n = 152) u f’9.4% tal-pazjenti fil-grupp tal-plaċebo (n = 149).